<p>NOTE: N, represents the total number of individuals who have a G6PD activity level below the specified cut-off point; RR, relative risk.</p><p>NOTE: Table depicts how the relative risk of malaria varies depending on the cut-off point for determining G6PD deficiency by enzymatic assay.</p>*<p>Sample sizes are too small for meaningful analysis of enzymatically deficient females in these categories.</p
Background: Primaquine is a key drug for malaria elimination. In addition to being the only drug act...
BACKGROUND The distribution of the enzymopathy glucose-6-phosphate dehydrogenase (G6PD) deficienc...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder characterized by...
BackgroundClinical association studies have yielded varied results regarding the impact of glucose-6...
Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate...
G6PD deficiency is believed to confer protection against Plasmodium falciparum malaria, but it has p...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
<p>* Adjusted median (100% G6PD activity): an adjusted median value is calculated for which males wi...
Background Glucose-6-phosphate dehydrogenase (G6PD) activity is dependent upon G6PD genotype and age...
<p>G6PD deficiency prevalence, testing, and primaquine policies in American malaria-endemic countrie...
Abstract. A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected pati...
gametocytes, and may interrupt transmission and help contain the spread of artemisinin resistance. ...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a X-chromosomally transmitted disorder of the...
Background: Primaquine is a key drug for malaria elimination. In addition to being the only drug act...
BACKGROUND The distribution of the enzymopathy glucose-6-phosphate dehydrogenase (G6PD) deficienc...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder characterized by...
BackgroundClinical association studies have yielded varied results regarding the impact of glucose-6...
Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate...
G6PD deficiency is believed to confer protection against Plasmodium falciparum malaria, but it has p...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
<p>* Adjusted median (100% G6PD activity): an adjusted median value is calculated for which males wi...
Background Glucose-6-phosphate dehydrogenase (G6PD) activity is dependent upon G6PD genotype and age...
<p>G6PD deficiency prevalence, testing, and primaquine policies in American malaria-endemic countrie...
Abstract. A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected pati...
gametocytes, and may interrupt transmission and help contain the spread of artemisinin resistance. ...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a X-chromosomally transmitted disorder of the...
Background: Primaquine is a key drug for malaria elimination. In addition to being the only drug act...
BACKGROUND The distribution of the enzymopathy glucose-6-phosphate dehydrogenase (G6PD) deficienc...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder characterized by...